WST
West Pharmaceutical Services Inc
NYSE: WST · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$337.46
+0.14% today
Updated 2026-07-29
Market cap
$25.31B
P/E ratio
47.83
P/S ratio
7.86x
EPS (TTM)
$7.49
Dividend yield
0.24%
52W range
$208 – $368
Volume
0.8M
West Pharmaceutical Services Inc (WST) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$337.46
12-Month target
$203.74
2030 Target
—
Intrinsic (DCF)
$160.53
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.8B | $2.9B | $3.0B | $2.9B | $3.1B | $3.3B | $3.5B | $3.8B | $4.1B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 7.44% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 16.90%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.